Icl Group Ltd. · TASE:ICL
Icl — Investor Day (October 2022)
20 slides from Icl's investor day presentation, Oct 25, 2022
Slide 1: Growing Specialties Impact
Growing Specialties Impact Elad Aharonson President, Growing Solutions October 25, 2022 ICL Investor Day 1
Slide 2: Important legal notes
Important legal notes Disclaimer and safe harbor for forward-looking statements This presentation and/or other oral or written statements made by ICL Group during its presentation, or from time to time, may contain forward-looking statements within the meaning of the United States Private Securities
Slide 3: Our Winning Aspiration: Global Leader in Specialty Plant Nutrition
= oe 2 =r Our Winnin . Aspiration : € To Become the Global Leader in Specialty Plant Nutrition
Slide 4: Specialty plant nutrition market - US$B
Specialty plant nutrition market - US$B Need for higher agriculture yield yield Global resources decreasing, as population increases, 22.6 22.6 driving growing demand for improved yields 21.1 21.1 3 3 19.9 19.9 18.7 18.7 Global environmental awareness 11 17.6 16.5 16.5 17.6 New Green regulations exp
Slide 5: Results ahead of previous 2020 to 2025 plan
Results ahead of previous 2020 to 2025 plan Sales US$M Successful M&A and integration in 2,262 1,863 Brazil drove better than expected results 1,670 1,033 Optimization of sales and marketing channels 2020* 2025 Target 2021 TTM EBITDA US$M 395 Favorable market acceptance of FertilizerpluS products 21
Slide 6: On track to become the global leader in specialty plant nutrition!
ICL specialty plant nutrition vs. peers US$B Leaders >$2.0B Medium Players $0.5B to $1.0B Small Players < $0.5B On track to become the global leader in specialty plant nutrition! Source: Internal market research. 6
Slide 7: On track to become the global leader in specialty plant nutrition!
ICL specialty plant nutrition vs. peers US$B Leaders >$2.0B Medium Players $0.5B to $1.0B Small Players < $0.5B On track to become the global leader in specialty plant nutrition! Source: Internal market research. 7
Slide 8: On track to become the global leader in specialty plant nutrition!
ICL specialty plant nutrition vs. peers US$B Leaders >$2.0B 2027 Medium Players $0.5B to $1.0B Small Players < $0.5B On track to become the global leader in specialty plant nutrition! Source: Internal market research. 8
Slide 9: Global leader in specialty plant nutrition
Innovative & Geographic Operational Data Driven M&A and Sustainable Expansion Optimization Ag Services Partnerships Offerings Focused on & Vertical Enhance & Major Markets Integration Enable Global leader in specialty plant nutrition Note: Segment EBITDA and EBITDA margin are non-GAAP financial meas
Slide 10: Global Leaders in CRF Technology, Fertigation and Professional Markets
Global Leaders in CRF Technology First to launch biodegradable coating solution Leading in Fertigation Solutions Nutrient Use Focus on growth in India and China Efficiency Global Leaders in Professional Markets Turf, Ornamental and Horticulture Biostimulants & Beyond Biostimulants Robust pipeline of
Slide 11: More Precise, Sustainable & Efficient Agriculture
Nutrient Use Efficiency More Precise, Sustainable & Efficient Agriculture Biostimulants Digitally enhanced, data driven insights & Beyond from on-field resources and remote sensing to improve performance and drive Organic best in class sustainable agriculture; & Recycled optimizing inputs, crops and
Slide 12: Focus on growth opportunities
Focus on Focus on growth growth opportunities opportunities Brazil Brazil China & China & India India USA USA Production Production Successful integration of Fertigation focused Focus on high margin Growth & Growth & the acquired companies markets specialty crops Optimization Optimization Leading th
Slide 13: Major markets – balance and focus
Major markets – balance and focus Sales by Region NORTH NORTH AMERICA AMERICA & ROW & ROW SOUTH 16% AMERICA NORTH SOUTH 7% AMERICA AMERICA & ROW 35% 10% 6% ASIA 21% SOUTH 35% AMERICA ASIA 19% ASIA 30% 54% EUROPE 37% 30% EUROPE EUROPE Notes: TTM reflects trailing 12 months through 2Q’22. Amounts show
Slide 14: Eco-system to provide unmatched value to Growers
Eco-system to provide unmatched value to Growers AI driven agronomic Quantifying Carbon Footprint prescriptions leveraging big (CFP) of plant nutrition plans data from field trials, remote & optimizing crop sensing, plant and soil data management practices at field-level E-Commerce - seamless servic
Slide 15: Eco-system to provide unmatched value to Growers
Eco-system to provide unmatched value to Growers AI driven agronomic Quantifying Carbon Footprint 1 prescriptions leveraging big (CFP) of plant nutrition plans data from field trials, remote & optimizing crop sensing, plant and soil data management practices at field-level 2 E-Commerce - seamless se
Slide 16: On track to become the global leader in specialty plant nutrition: 2021 to 2027
2021 to 2027 Sales US$M EBITDA US$M Target Target Target Target On track to become the global leader in specialty plant nutrition Note: Segment EBITDA is a non-GAAP financial measure; see reconciliation tables in appendix. 16
Slide 17: Updated 5Y plan
Updated 5Y plan 1 Delivered on 2020 promises much sooner than expected. 2 Significant market opportunity large, growing and becoming more sophisticated. 3 Right fundamentals in place we are well prepared to outperform the market growth. On track to become the global leader in specialty plant nutriti
Slide 18: Thank you
ANCL Thank you 806006
Slide 19: Reconciliation tables
Reconciliation tables Industrial Products US$M 2017 2018 2019 2020 2021 TTM Potash US$M 2019 2020 2021 TTM Segment sales $1,193 $1,296 $1,318 $1,255 $1,617 $1,789 Segment sales $1,421 $1,268 $1,776 $2,793 Segment operating income $247 $300 $338 $303 $435 $595 Segment operating income $289 $121 $399
Slide 20: Long-term targets and non-GAAP financial measures
Long-term targets and non-GAAP financial measures Long term targets The company only provides long term targets on a non-GAAP basis. The company does not provide a reconciliation of forward-looking targeted EBITDA (non-GAAP) and targeted Margin EBITDA (non-GAAP) to GAAP net income (loss), due to the